Foghorn Therapeutics
IPO- Headquarters
- Watertown, Massachusetts
- Business Model
- B2B
- Website
- foghorntx.com
- Type
- Public
About
Clinical-stage biotech pioneering medicines that treat serious diseases by correcting abnormal gene expression.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSimilar Companies

Eikon TherapeuticsIPO
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Hayward, United States201–500Artificial Intelligence, Drug Discovery
Series D·$1.1B·Feb 2025

Canopy Growth Corporation Common SharesIPO
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Smiths Falls, Canada1001–5000healthtech, Healthcare
Corporate Round·$4.5B·Jan 2024
inVentiv HealthAcquired
Biopharmaceutical services company
United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004

AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Hugel
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Chuncheon, South Korea201–500Aesthetics, Biotech
Private Equity·$2.3B·Aug 2021